We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BBLG market cap is 2.25M. The company's latest EPS is USD -4.9677 and P/E is -0.25.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.04M | -2.08M | -1.16M | -903k | -810k |
| Net Income | -1.77M | -1.92M | -1.55M | -866k | -784k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.45M | -825k | -1.1M | -3.67M | -9.43M |
| Net Income | -3.43M | -1.83M | -1.61M | -1.49M | -8.95M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.62M | 4.98M | 3.74M | 3.84M | 3.19M |
| Total Liabilities | 1.93M | 1.18M | 832k | 165k | 284k |
| Total Equity | 5.69M | 3.79M | 2.91M | 3.68M | 2.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31k | 0 | 6.68M | 8.5M | 3.74M |
| Total Liabilities | 11.9M | 13.69M | 100k | 2.55M | 832k |
| Total Equity | -11.87M | -13.69M | 6.58M | 5.95M | 2.91M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.98M | -7.54M | -9.56M | -1.3M | -2.2M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.45M | 4.45M | 5.04M | 1.5M | 1.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.25M | -427k | -1.23M | -3.57M | -9.56M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.32M | 403k | 7.9M | 4.43M | 5.04M |
| Market Cap | 2.25M |
| Price to Earnings Ratio | -0.25 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.74 |
| Price to Book Ratio | 0.77 |
| Dividend Yield | - |
| Shares Outstanding | 1.8M |
| Average Volume (1 week) | 53.72k |
| Average Volume (1 Month) | 114.09k |
| 52 Week Change | -69.45% |
| 52 Week High | 10.56 |
| 52 Week Low | 0.80 |
| Spread (Intraday) | 0.05 (3.91%) |
| Company Name | Bone Biologics Corporation |
| Address |
1013 centre road wilmington, delaware 19805 |
| Website | https://www.bonebiologics.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
